NCT00302549View on ClinicalTrials.gov

To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LN

NACompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

May 31, 2005

Study Completion Date

February 28, 2006

Conditions
Lupus Nephritis
Interventions
DRUG

FK506

FK506,0.1mg/kg/d

Trial Locations (1)

210002

Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine, Nanjing

All Listed Sponsors
collaborator

Sun Yat-sen University

OTHER

lead

Nanjing University School of Medicine

OTHER

NCT00302549 - To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LN | Biotech Hunter | Biotech Hunter